Original Research

Published on 05 Oct 2022

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma

in Cancer Metabolism

Zhen Wang
Gentao Fan
Hao Zhu
Lingfeng Yu
Diankun She
Yanting Wei
Jianhao Huang
Tianhang Li
Shoubin Zhan
Shenkai Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.980390

4,356 views
13 citations

Perspective

Published on 05 Oct 2022

Malnutrition management in oncology: An expert view on controversial issues and future perspectives

in Cancer Metabolism

Paolo Bossi
Raffaele De Luca
Oriana Ciani
Elisa D’Angelo
Riccardo Caccialanza

Frontiers in Oncology

doi 10.3389/fonc.2022.910770

8,907 views
14 citations

Mini Review

Published on 04 Oct 2022

GAPDH in neuroblastoma: Functions in metabolism and survival

in Cancer Metabolism

Kevin Cornett
Anna Puderbaugh
Olivia Back
Rolf Craven

Frontiers in Oncology

doi 10.3389/fonc.2022.979683

5,475 views
9 citations

Original Research

Published on 04 Oct 2022

Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer

in Cancer Metabolism

Tiefeng Cao
Jiaqi Dong
Jiaming Huang
Zihao Tang
Huimin Shen

Frontiers in Oncology

doi 10.3389/fonc.2022.979565

2,659 views
4 citations

Original Research

Published on 04 Oct 2022

Relationship between standardized uptake value on 18F-FDG PET and PD-L1 expression in clear cell renal cell carcinoma

in Cancer Metabolism

Ying Liu
Yanlei Huo
Chao Ma
Zhongwei Lv

Frontiers in Oncology

doi 10.3389/fonc.2022.1012561

2,313 views

Original Research

Published on 30 Sep 2022

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis

in Cancer Metabolism

Adithya Chedere
Madhulika Mishra
Omkar Kulkarni
Shrisruti Sriraman
Nagasuma Chandra

Frontiers in Oncology

doi 10.3389/fonc.2022.954512

3,738 views
5 citations

Mini Review

Published on 29 Sep 2022

Understanding emerging bioactive metabolites with putative roles in cancer biology

in Cancer Metabolism

Olivier Philips
Mukhayyo Sultonova
Beau Blackmore
J. Patrick Murphy

Frontiers in Oncology

doi 10.3389/fonc.2022.1014748

2,684 views
1 citation

Original Research

Published on 29 Sep 2022

Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs

in Cancer Metabolism

Chenyang Li
Qian Liu
Yiran Song
Wenxin Wang
Xiaolan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.944476

2,033 views
1 citation

Original Research

Published on 28 Sep 2022

The association between biomarkers of acrylamide and cancer mortality in U.S. adult population: Evidence from NHANES 2003-2014

in Cancer Metabolism

Wenbo Gu
Jiacheng Zhang
Chunling Ren
Yang Gao
Tongfang Zhang
Yujia Long
Wei Wei
Shaoying Hou
Changhao Sun
Changhong Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.970021

3,989 views
5 citations

Original Research

Published on 26 Sep 2022

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide

in Cancer Metabolism

Alessia Lodi
Renu Pandey
Jennifer Chiou
Ayon Bhattacharya
Shiliang Huang
Xingxin Pan
Brandon Burgman
S. Stephen Yi
Stefano Tiziani
Andrew J. Brenner

Frontiers in Oncology

doi 10.3389/fonc.2022.900082

2,572 views
4 citations

Original Research

Published on 23 Sep 2022

GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide

in Cancer Metabolism

Sweta Parik
Juan Fernández-García
Francesca Lodi
Karen De Vlaminck
Marleen Derweduwe
Steven De Vleeschouwer
Raf Sciot
Wietse Geens
Linqian Weng
Francesca Maria Bosisio

Frontiers in Oncology

doi 10.3389/fonc.2022.988872

5,990 views
22 citations

Original Research

Published on 21 Sep 2022

Platinum-based drug-induced depletion of amino acids in the kidneys and liver

in Cancer Metabolism

Katerina Mitrevska
Natalia Cernei
Hana Michalkova
Migue Angel Merlos Rodrigo
Ladislav Sivak
Zbynek Heger
Ondrej Zitka
Pavel Kopel
Vojtech Adam
Vedran Milosavljevic

Frontiers in Oncology

doi 10.3389/fonc.2022.986045

2,141 views
2 citations

Review

Published on 21 Sep 2022

Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche

in Cancer Metabolism

Antonio Giovanni Solimando
Eleonora Malerba
Patrizia Leone
Marcella Prete
Carolina Terragna
Michele Cavo
Vito Racanelli

Frontiers in Oncology

doi 10.3389/fonc.2022.973836

7,313 views
17 citations

Review

Published on 20 Sep 2022

Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment

in Cancer Metabolism

Takeru Maekawa
Toru Miyake
Masaji Tani
Shinji Uemoto

Frontiers in Oncology

doi 10.3389/fonc.2022.981547

7,527 views
10 citations

Mini Review

Published on 20 Sep 2022

Differential glutamine metabolism in the tumor microenvironment – studies in diversity and heterogeneity: A mini-review

in Cancer Metabolism

Michael D. Claiborne
Robert Leone

Frontiers in Oncology

doi 10.3389/fonc.2022.1011191

3,933 views
9 citations

Review

Published on 16 Sep 2022

Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy

in Cancer Metabolism

Remya Nair
Pulkit Gupta
Mala Shanmugam

Frontiers in Oncology

doi 10.3389/fonc.2022.1000106

6,097 views
10 citations

Navigation group

Articles

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma

Malnutrition management in oncology: An expert view on controversial issues and future perspectives

GAPDH in neuroblastoma: Functions in metabolism and survival

Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer

Relationship between standardized uptake value on 18F-FDG PET and PD-L1 expression in clear cell renal cell carcinoma

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis

Understanding emerging bioactive metabolites with putative roles in cancer biology

Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs

The association between biomarkers of acrylamide and cancer mortality in U.S. adult population: Evidence from NHANES 2003-2014

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide

GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide

Platinum-based drug-induced depletion of amino acids in the kidneys and liver

Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche

Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment

Differential glutamine metabolism in the tumor microenvironment – studies in diversity and heterogeneity: A mini-review

Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy